patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: review -Dr. Annex joins the following esteemed members of PSTI's Advisory Board

review -Dr. Annex joins the following esteemed members of PSTI's Advisory Board

posted on Aug 11, 2008 08:31AM

Dr. Annex joins the following esteemed members of Pluristems Advisory Board:



  • Edwin M. Horwitz, MD, PhD Chairman - Dr. Horwitz currently serves as the Director of Cell Therapy in the Division of Oncology / Blood & Marrow Transplantation at Childrens Hospital of Philadelphia.
  • Arnon Nagler, MD Dr. Nagler is currently Professor of Medicine at Tel Aviv University Sackler School of Medicine.
  • Jacob Michael Rowe, M.D., F.A.C.P. Dr. Rowe is currently Dresner Professor of Hemato-oncology and Vice Dean for Clinical Appointments at the Bruce Rappaport Faculty of Medicine of the Technion, Israel Institute of Technology and is also an Adjunct Professor at the Department of Medicine of Northwestern University, Chicago, IL.
  • Ron Gonen, MD Dr. Gonen is currently the Senior Deputy Chairman of the Department of Obstetrics and Gynecology and the Director of Maternal Fetal Medicine at the Bnai-Zion Medical Center, Haifa, Israel.
  • Avinoam Kadouri PhD - Dr. Kadouri is one of the leading scientists in industrial biotechnology with a worldwide reputation. He has 15 years experience as R&D Director and worldwide Process Development Director at Serono International.
  • Abraham Treves PhD Dr. Treves is currently the Executive Deputy of Israels Sheba Cancer Research Center and was the founder, President and CEO of Gamida-Cell Ltd., an Israeli biotechnology company working in the field of HSC expansion.
Share
New Message
Please login to post a reply